What is the size of the Cancer Therapy Market?
According to 6Wresearch internal database and industry insights, the
Global Cancer Therapy Market was exhibited at USD 191 billion in 2024 and is projected to reach USD 326 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2025â2031.
Due to the increasing global cancer burden, advancements in immunotherapy and targeted treatments, and greater access to innovative therapies worldwide, the market is predicted for the strong growth in the upcoming years.
Key Growth Factors of the Cancer Therapy Market
- Increasing incidence of various cancers globally
- Rapid advancements in precision medicine and immunotherapies
- Expanding government and private sector investment in oncology
- Accelerated drug approvals and clinical pipeline expansion
- Rising awareness and access to modern therapies in emerging economies
Cancer Therapy Market Trends
The cancer therapy market is moving forward with rising shift towards the personalized treatment regimens which involves the genomic testing and biomarker-driven therapies. Further, the immunotherapies like checkpoint inhibitors and CAR-T cell therapy are revolutionizing treatment protocols. Furthermore, AI-based clinical decision tools and real-world evidence are supporting more accurate and effective treatment planning. Together, all these trends are reshaping the dynamics of the market.
Emerging Developments in the Cancer Therapy Market
Cancer therapy market is seeing few developments with technologies such as CRISPR gene editing, RNA-based therapies, and tumour microenvironment modulation are at the forefront of innovation.
At the other side, the collaborative efforts between biotech firms, academic institutions, and healthcare providers are accelerating the development of next-gene therapies with fewer side effects and improved survival outcomes.
Leading Companies in the Cancer Therapy Market
- Roche
- Bristol-Myers Squibb
- Merck & Co.
- Pfizer
- Novartis
- AstraZeneca
- Eli Lilly and Company
- Amgen
- Johnson & Johnson
- Gilead Sciences
How big is the Cancer Therapy Market : FAQ's
The cancer therapy market was exhibited at USD 191 billion in 2024 and is projected to reach USD 326 billion by 2031.
High cancer incidence, demand for advanced therapies, and strong investment in oncology innovation.
Rise in immunotherapies, personalized treatment approaches, and AI-supported oncology care.
Key companies include Roche, Merck, BMS, Pfizer, and Novartis.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com